Literature DB >> 12015532

Costs and consequences of comprehensive stillbirth assessment.

Scott T Michalski1, Jason Porter, Richard M Pauli.   

Abstract

OBJECTIVE: The purpose of this study was to determine the consequences and costs of comprehensive stillbirth assessment. STUDY
DESIGN: Through reconstruction, we determined what consequences arise from assessment in the first 1477 stillborn pregnancies that were referred to the Wisconsin Stillbirth Service Program. Economic costs of stillbirth assessment were derived from real-time studies of those who performed the analyses and the costs of materials that were consumed.
RESULTS: When comprehensive, nonselective analysis is performed, new information that is relevant to recurrence risk estimation, prenatal diagnosis recommendation, or preconceptual, prenatal, perinatal, or neonatal treatment will arise in 51% of stillborn infants. The real cost of such assessment is approximately $1450 per assessment, or approximately $12 per cared-for pregnancy.
CONCLUSION: Substantial relevant information can be learned from stillbirth assessment at a modest economic cost. Programs that can provide comprehensive stillbirth assessment services should become part of routine pregnancy care.

Entities:  

Mesh:

Year:  2002        PMID: 12015532     DOI: 10.1067/mob.2002.122450

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Fetal death certificates as a source of surveillance data for stillbirths with birth defects.

Authors:  C Wes Duke; C J Alverson; Anolfo Correa
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

2.  Human fetal whole-body postmortem microfocus computed tomographic imaging.

Authors:  Ian C Simcock; Susan C Shelmerdine; J Ciaran Hutchinson; Neil J Sebire; Owen J Arthurs
Journal:  Nat Protoc       Date:  2021-04-14       Impact factor: 13.491

Review 3.  Interventions for investigating and identifying the causes of stillbirth.

Authors:  Aleena M Wojcieszek; Emily Shepherd; Philippa Middleton; Glenn Gardener; David A Ellwood; Elizabeth M McClure; Katherine J Gold; Teck Yee Khong; Robert M Silver; Jan Jaap Hm Erwich; Vicki Flenady
Journal:  Cochrane Database Syst Rev       Date:  2018-04-30

Review 4.  Perinatal death investigations: What is current practice?

Authors:  J W Nijkamp; N J Sebire; K Bouman; F J Korteweg; J J H M Erwich; S J Gordijn
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-18       Impact factor: 3.926

Review 5.  A structured review and exploration of the healthcare costs associated with stillbirth and a subsequent pregnancy in England and Wales.

Authors:  Hema Mistry; Alexander E P Heazell; Oluwaseyi Vincent; Tracy Roberts
Journal:  BMC Pregnancy Childbirth       Date:  2013-12-17       Impact factor: 3.007

6.  Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

Authors:  Makoto Saito; Rashid Mansoor; Kalynn Kennon; Anupkumar R Anvikar; Elizabeth A Ashley; Daniel Chandramohan; Lauren M Cohee; Umberto D'Alessandro; Blaise Genton; Mary Ellen Gilder; Elizabeth Juma; Linda Kalilani-Phiri; Irene Kuepfer; Miriam K Laufer; Khin Maung Lwin; Steven R Meshnick; Dominic Mosha; Atis Muehlenbachs; Victor Mwapasa; Norah Mwebaza; Michael Nambozi; Jean-Louis A Ndiaye; François Nosten; Myaing Nyunt; Bernhards Ogutu; Sunil Parikh; Moo Kho Paw; Aung Pyae Phyo; Mupawjay Pimanpanarak; Patrice Piola; Marcus J Rijken; Kanlaya Sriprawat; Harry K Tagbor; Joel Tarning; Halidou Tinto; Innocent Valéa; Neena Valecha; Nicholas J White; Jacher Wiladphaingern; Kasia Stepniewska; Rose McGready; Philippe J Guérin
Journal:  BMC Med       Date:  2020-06-02       Impact factor: 8.775

7.  Persistent inaccuracies in completion of medical certificates of stillbirth: A cross-sectional study.

Authors:  Lucy E Higgins; Alexander E P Heazell; Melissa K Whitworth
Journal:  Paediatr Perinat Epidemiol       Date:  2018-10-09       Impact factor: 3.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.